亞洲及大洋洲的EMR市場:2022年

在亞洲，由於醫療機關脫離COVID-19流行的高峰，EMR的購買判斷活性化。在大洋洲，大部分的公立醫院導入EMR，不過，因為許多公立、私立醫療機關計劃未來大規模購買EMR，購買意願依然旺盛。

本報告以亞洲、大洋洲地區專門，最近的EMR購買決策的市場佔有率和供應商的能源，依據客戶的回饋和經驗的各地區的供應商的效能介紹。

目錄

第1章 執行見解

第2章 洞察的擴大

第3章 供應商的洞察

• 客戶採訪詳細內容
• Altera Digital Health(Allscript)
• Epic
• ezCaretech
• InterSystems
• IQVIA
• Oracle Health (Cerner)
• Telstra Health

第4章 資料目錄

As healthcare organizations have come out of the peak of the COVID-19 pandemic, EMR purchase decisions in Asia have ramped up. In Oceania, most public hospitals have an EMR in place, but purchase energy remains high since many public and private provider organizations are planning large-scale purchases of go-forward EMRs. This report-KLAS' first focused exclusively on Asia and Oceania-highlights (1) market share and vendor energy in recent EMR purchase decisions and (2) vendor performance in each region based on client feedback and experience. The chart below offers a high-level view of vendors' overall performance.

Table of Contents

1. Executive Insights

2. Expanded Insights

3. Vendor Insights

• a. Customer Interview Details Altera Digital Health (Allscripts)
• b. Epic
• c. ezCaretech
• d. InterSystems
• e. IQVIA
• f. Oracle Health (Cerner)
• g. Telstra Health

4. Data Index